Matthew Parris

Mr. Parris joined Onconova Therapeutics in August 2018 as Senior Director, Clinical Operations, and is responsible for overseeing and managing the Clinical Operations team and the cross functional project teams. He was promoted to Vice President, Clinical Operations in January 2021.

Mr. Parris has clinical development experience in multiple therapeutic areas, with a focus on Oncology and Hematology indications across a wide variety of therapeutic agents. He has over 24 years of industry experience, initially in Europe and since 2003 in the United States, holding management positions in contract research organizations as well as small pharma companies.

Previously, Mr. Parris served as Director of Clinical Operations for Inovio Pharmaceuticals, Vice President of Clinical Development for Eleison Pharmaceuticals, and Director of Clinical Operations at Aegerion Pharmaceuticals. He has a Bachelor of Science Degree, with honors, from Imperial College in London.